Glaxosmithkline | GSK - 营业费用



金融业
股票价格
GBP 48.73
资产
GBP 71.7B
现金及等价物
GBP 2.93B
销售成本
GBP 2.39B
流动资产
GBP 17.9B
流动负债
GBP 20.72B
债务
GBP 23.7B
股息收益率
GBP 1.88
EBIT
GBP 2.15B
EBITDA
GBP 2.93B
员工
GBP 69.4K
EPS每股收益
GBP 0.76
股本和储备
GBP 18.36B
销售毛利
GBP 6.5B
债务利息支出
GBP 264.74M
利息收入
GBP 29M
贷款资金
GBP 28.79B
市值
GBP 102.3B
净收入
GBP 1.54B
营业费用
GBP 6.76B
营业利润
GBP 2.13B
普通股股本
GBP 2.02B
PE价格收益
15.17
税前利润
GBP 1.94B
销售收入
GBP 8.89B
销售和管理费用
GBP 2.38B
股票
GBP 6.3B
贸易债权人
GBP 15.63B
应收帐款人
GBP 11.31B


营业费用 更改 日
AbbVie USD 10.52B 258M 2026-09
Amgen USD 11.69B 6.9B 2026-06
AstraZeneca USD 11.55B 674M 2026-09
Aurora Cannabis CAD 76.28M 28.24M 2026-06
Bausch Health Companies USD 1.95B 128M 2026-09
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Canopy Growth CAD 98.74M 23K 2026-06
Corcept Therapeutics USD 214.85M 343K 2026-06
Drreddys Laboratories INR 73.9B 431M 2026-09
Eli Lilly USD 10.52B 496M 2026-06
GlaxoSmithKline GBP 6.03B 227M 2026-09
Glaxosmithkline GBP 6.76B 1.42B 2026-09
J&J USD 18.93B 1.09B 2026-09
Merck USD 10.75B 5.02B 2026-09
Novartis USD 9.88B 325M 2026-09
Pacira USD 180.54M 7.79M 2026-06
Perrigo USD 290.5M 645.1M 2026-06
Pfizer USD 89B 3.81B 2026-09
Phibro Animal Health USD 361.83M 29.47M 2026-03
Prestige Brands USD 213.19M 7.06M 2026-06
Roche Holding CHF 18.9B 2.12B 2026-06
Sanofi EUR 10.51B 598M 2026-09
Supernus Pharmaceuticals USD 1.06B 31.25M 2026-09
Takeda JPY 981.78B 36.71B 2026-09
Teva Pharmaceutical Industries USD 3.92B 691M 2026-06
Zoetis USD 3.15B 85M 2026-06